MOR - MorphoSys GAAP EPS of -Euro3.50 revenue of Euro63.8M
2023-11-15 16:03:12 ET
More on MorphoSys
- MorphoSys: Pelabresib Data Coming Out Soon, More Room To Run
- MorphoSys: Stable Liquidity Amid Challenging Markets
- I-Mab gains FDA breakthrough tag for kidney disease therapy
- MorphoSys expects a 5% surge in Monjuvi sales for Q3
- Seeking Alpha’s Quant Rating on MorphoSys
For further details see:
MorphoSys GAAP EPS of -€3.50, revenue of €63.8M